metabolism and generation of reactive oxygen species (ROS). Thus, mitochondrial 23 dysfunction directly promotes cell death, inflammation and oxidative stress, and 24 alters metabolism. These are key processes in atherosclerosis and there is now 25 evidence that mitochondrial DNA (mtDNA) damage leads to mitochondrial 26 dysfunction and promotes atherosclerosis directly. In this review we discuss the 27 recent evidence for and mechanisms linking mtDNA defects and atherosclerosis, and 28 suggest areas of mitochondrial biology that are potential therapeutic targets. Inflammatory factors released by macrophages stimulate the migration and/or 47 proliferation of vascular smooth muscle cells (VSMCs) [1] . VSMCs are important for 48 plaque stability, as they secrete the extra-cellular matrix that forms a fibrous cap. 49
However, VSMC death, fibrous cap thinning and subsequent plaque vulnerability 50 may be induced by inflammation [2] . 51 52 Inflammation, cell death and oxidative stress are therefore key processes driving 53 plaque development and transition to a vulnerable plaque phenotype [3, 4] . As 54 mitochondrial dysfunction can promote these pro-atherogenic processes, 55 mitochondrial damage has been implicated in atherogenesis, including damage to 56 mitochondrial DNA (mtDNA) [5] . However, the finding that mtDNA defects can 57 example, hyperglycaemia increases superoxide production whilst cigarette smoking 108 promotes the reduction of oxygen to form ROS [17] . Interestingly mtDNA defects in 109 circulating cells can be associated with diabetes, although a causal role could not be 110 proven [6] . 111
112
Apart from oxidative damage, replication errors are another source of mtDNA 113
defects. Lesions such as point mutations can form in early life, and undergo clonal 114 expansion to reach a threshold level where mitochondrial function is impaired [11] . 115 mtDNA lesions may persist as mitochondria have a reduced capacity for DNA 116 damage repair; whilst mitochondrial base excision repair has been well described, 117 nucleotide excision repair is lacking [10] . 118 119
Inflammation -a link between mitochondria and atherosclerosis 120
Once mtDNA defects are present, they can result in decreased respiratory subunit 121 formation, impaired mitochondrial respiration and reduced ATP content [18] . 122
Furthermore, cellular phenotype is also altered as mtDNA defects and dysfunction 123 result in a pro-inflammatory profile that likely promotes plaque vulnerability [6] . 124
Thinning of the fibrous cap and increased necrotic core area (features of vulnerable 125 plaque) were observed in apolipoprotein E deficient recipients of mutator mouse 126 bone marrow. Isolated monocytes from mutator mice show mtDNA damage and 127 increased release of tumour necrosis factor alpha (TNFα) and interleukin 1 (IL1β) 128
[6]. These findings are consistent with the growing body of work identifying multiple 129 mechanisms linking mitochondria and inflammation, a key atherogenic process. Overall the evidence from human and mouse studies suggests that oxidative stress 222 is present and promotes atherosclerosis. However, whether increased ROS mediates 223 the effects of mtDNA damage is more uncertain. For example, when first described 224 mutator mice showed no evidence of increased oxidative stress despite extensive 225 mtDNA lesions [16, 36] . In contrast, later work showed that reducing mitochondrial 226 ROS with over-expression of mitochondrial-targeted catalase partially rescued a 227 cardiomyopathy phenotype [37] . One of the difficulties in the field has been the ability 228 to assess ROS accurately in vivo, and this may account for differing findings in 229 published studies. The conventional methods of measuring ROS rely on redox-230 sensitive dyes that are taken up into the cytoplasm or mitochondria. In 231 atherosclerosis these dyes can lack both sensitivity and specificity, in part because of 232 autofluorescence of both the normal vessel wall and plaque components. In contrast, 233 the mitochondria-targeted ratiometric probe MitoB accumulates within mitochondria, 234
where it reacts with hydrogen peroxide to form MitoP [38] . The NLRP3 inflammasome is a multi-protein complex composed of NLRP3, the 599 adapter protein ASC and pro-caspase 1 (pro casp 1). Once activated caspase 1 600 cleaves pro-IL1β into its mature form. Dysfunctional mitochondrial generate reactive 601 oxygen species (ROS), externalize cardiolipin (CL) and release mitochondrial DNA 602 (mtDNA), all of which can activate NLRP3. NAD/NADH levels are also decreased, 603 leading to decreased sirtuin 2 activity and the accumulation of α-acetylated tubulin 604 that promotes NLRP3 and ASC colocalisation. mtDNA also has significant amounts 605 of unmethylated DNA as CpG islands, which activate NFκβ signaling and increased 606 cytokine expression through toll-like receptor 9 (TLR9). 
